AAA
VERA icon

Affinity Asset Advisors’s Vera Therapeutics VERA Stock Holding History

Affinity Asset Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Hold
250,000
– – 0.59% 49
2025
Q4 		$12.7M Sell
250,000
-53,330
-18% -$1.89M 0.91% 39
2025
Q3 		$8.81M Sell
303,330
-241,670
-44% -$5.59M 0.82% 37
2025
Q2 		$12.8M Buy
545,000
+189,857
+53% +$4.27M 1.9% 18
2025
Q1 		$8.53M Sell
355,143
-69,857
-16% -$2.24M 1.34% 28
2024
Q4 		$18M Sell
425,000
-10,000
-2% -$443K 2.81% 14
2024
Q3 		$19.2M Buy
435,000
+60,000
+16% +$2.28M 2.98% 11
2024
Q2 		$13.6M Sell
375,000
-95,000
-20% -$3.77M 2.14% 18
2024
Q1 		$20.3M Buy
+470,000
New +$16.7M 3.29% 11

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return